Nektar Therapeutics (NasdaqCM:NKTR) 2025 Conference Transcript

Nektar Therapeutics (NasdaqCM:NKTR) 2025 Conference November 20, 2025 06:00 AM ET Company ParticipantsJonathan Zalevsky - Chief Research and Development OfficerConference Call ParticipantsRoger Song - Senior AnalystRoger SongAll right. Welcome, everyone, to Jefferies Linda Healthcare Conference 2025, last day. Thank you for everyone in the room. And my name is Roger Song, one of the senior analysts covering biotech in the U.S. It is my pleasure to have a fireside chat with our next company, Nektar Therapeut ...